Spine Takes Yuhan’s Peptide Into US Phase III For High-Need DDD

Second Asset In Global Pivotal Trials

 
• By Jung Won Shin
  
back pain
Treatment Aims To Change Standard Of Care For CLBP patients • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia